Most healthcare pricing products show you a number. TruCost shows you the context, the alternatives, and the path to action, embedded in the workflows where decisions are actually made.
Our streaming pipeline handles 500GB+ per payer MRF files that crash standard analytics tools. Competitors access the same public data, but TruCost actually processes it at scale, continuously, without batch delays.
TruCost was founded by MD and MD/MBA candidates who have observed the pricing gap firsthand in clinical training. Product decisions are informed by how healthcare actually works, not how engineers imagine it does.
Raw MRF rates tell you what something costs. TruCost adds Social Determinants of Health pathways, state Medicaid data, and provider level service data, turning pricing data into care navigation intelligence.
TruCost does not ask users to remember to open another tab. Our tools are designed to live inside discharge workflows, revenue cycle processes, and prescribing moments, where decisions are actually made.
Payer MRFs update continuously. So does TruCost. We do not serve cached snapshots from last quarter. When you look up a rate, you are looking at the most current published data available anywhere.
Healthcare pricing regulation moves fast. IRA drug pricing reforms, CMS MRF Schema 2.0 compliance deadlines, Part D out of pocket caps: TruCost's team tracks every regulatory development and reflects it in the platform in real time.
Clinical and claims data companies already have deep patient level datasets. What they do not have is a clean, current, granular map from negotiated financial rates to established clinical ontologies. That crosswalk, not a competing national data corpus, is what TruCost builds and defends.
| Capability | TruCost | Generic Price Transparency Tools | Clinical / Claims Data Platforms |
|---|---|---|---|
| Continuous ingestion of 500GB+ payer MRF files | Yes | Partial | Rarely |
| Mapped to CPT, NPI, OMOP, FHIR/USCDI, SNOMED | Yes | Rarely | Partial |
| SDOH and Medicaid MCO enrichment | Yes | No | Partial |
| Embedded at discharge, prescribing, and negotiation moments | Yes | No | No |
| Free patient facing drug price tool | Yes | Varies | No |
This comparison reflects TruCost's own assessment of the general market category as of 2026 and is meant to describe the shape of the gap we are building for, not to make a specific claim about any single named competitor's roadmap.